Zhang Yuanyuan, Zhang Xinyi, Li Haitao, Liu Jianyong, Wei Wei, Gao Jie
Changhai Clinical Research Unit, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China.
Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.
Membranes (Basel). 2022 Jul 28;12(8):738. doi: 10.3390/membranes12080738.
The advent of immunotherapy, which improves the immune system's ability to attack and eliminate tumors, has brought new hope for tumor treatment. However, immunotherapy regimens have seen satisfactory results in only some patients. The development of nanotechnology has remarkably improved the effectiveness of tumor immunotherapy, but its application is limited by its passive immune clearance, poor biocompatibility, systemic immunotoxicity, etc. Therefore, membrane-coated biomimetic nanoparticles have been developed by functional, targeting, and biocompatible cell membrane coating technology. Membrane-coated nanoparticles have the advantages of homologous targeting, prolonged circulation, and the avoidance of immune responses, thus remarkably improving the therapeutic efficacy of tumor immunotherapy. Herein, this review explores the recent advances and future perspectives of cell membrane-coated nanoparticles for tumor immunotherapy.
免疫疗法的出现提高了免疫系统攻击和消除肿瘤的能力,为肿瘤治疗带来了新希望。然而,免疫治疗方案仅在部分患者中取得了令人满意的效果。纳米技术的发展显著提高了肿瘤免疫治疗的有效性,但其应用受到被动免疫清除、生物相容性差、全身免疫毒性等因素的限制。因此,通过功能性、靶向性和生物相容性细胞膜包被技术开发了膜包被仿生纳米颗粒。膜包被纳米颗粒具有同源靶向、循环时间延长和避免免疫反应等优点,从而显著提高了肿瘤免疫治疗的疗效。在此,本综述探讨了用于肿瘤免疫治疗的细胞膜包被纳米颗粒的最新进展和未来前景。